Results 81 to 90 of about 7,348 (201)

Endoscopically measured mucosal healing of delayed-release oral mesalamine 4.8 g/day versus 2.4 g/day [PDF]

, 2007
Gary R. Lichtenstein, Donald B. Rubin, Gino Regalli, Rachelle Eusebio   +3 more
openalex   +1 more source

P631. Mesalamine versus azathioprine for maintenance treatment after steroid-induced remission in pediatric ulcerative colitis [PDF]

, 2015
Christopher B. Michelsen, Signe Wildt, Lars Kristian Munck   +2 more
openalex   +1 more source

Effects of Mesalamine Treatment on Gut Barrier Integrity After Burn Injury

, 2016
Abigail R. Cannon, Suhail Akhtar, Adam M. Hammer, Niya L. Morris, Michael J. Javorski, Xiaoling Li, Richard H. Kennedy, Richard L. Gamelli, Mashkoor A. Choudhry   +8 more
openalex   +1 more source

Effects of Mesalamine Combined with Live Combined Bifidobacterium, Lactobacillus and Enterococcus Capsules on Intestinal Mucosa Barrier Function and Intestinal Microbiota in Mildly Active Crohn’s Disease Patients

Journal of Investigative Surgery
Objective: This study is aimed at investigating the impact of mesalamine combined with Live combined Bifidobacterium, Lactobacillus and Enterococcus capsules on intestinal mucosa barrier function and intestinal microbiota in mildly active Crohn’s disease
Meiqin Shen, Yingqi Shi, Zhenming Ge, Junbo Qian   +3 more
doaj   +1 more source

Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine [PDF]

, 2007
Sreedhar Subramanian, Jonathan M. Rhodes, Anthony C. Hart, Ben Tam, Carol L. Roberts, Shirley L. Smith, John E. Corkill, Craig Winstanley, Mumtaz Virji, Barry J. Campbell   +9 more
openalex   +1 more source

Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: Results of a multicentered placebo-controlled trial [PDF]

, 1998
Stephen B. Hanauer, (For the U.S. PENTASA Enema Study Group)   +1 more
openalex   +1 more source

Recurrent Pericarditis: A Rare Adverse Effect of Mesalamine [PDF]

, 2023
Pratul Karki, Ariya Kunwar, Nitish Sharma, Megha Dogra   +3 more
openalex   +1 more source

Late‐breaking trials in IBD

United European Gastroenterology Journal, Volume 13, Issue 9, Page 1818-1839, November 2025.
wiley   +1 more source

Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study [PDF]

Sumaiah J. Alarfaj, Sahar M. El-Haggar, Sahar K. Hegazy, M Maher, Monir M. Bahgat, Thanaa A. El‐Masry, Sarah Alrubia, Amsha S. Alsegiani, Mostafa M. Bahaa   +8 more
openalex   +1 more source

Dissolution of Commercially Available Mesalamine Formulations at Various pH Levels [PDF]

, 2015
Srini Tenjarla
openalex   +1 more source